Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Luckenbaugh

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
Psychiatry Research|August 9, 2017
Active suicidal ideation during clinical antidepressant trialsElizabeth D Ballard, Sam L Snider, Allison C Nugent, et al.
Journal of Affective Disorders|February 19, 2008
Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depressionChristoph Czermak, Richard Hauger, Wayne C Drevets, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 30, 2011
Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremorDietrich Haubenberger, Daniel Kalowitz, Fatta B Nahab, et al.
Biological Psychiatry|June 4, 2013
Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depressionMark J Niciu, David A Luckenbaugh, Dawn F Ionescu, et al.
Comprehensive Psychiatry|September 15, 2016
Recognition of emotional facial expressions in anxious and nonanxious depressionHannah E Berg, Elizabeth D Ballard, David A Luckenbaugh, et al.
Bipolar Disorders|May 29, 2016
Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD studyElizabeth D Ballard, Jennifer L Vande Voort, David A Luckenbaugh, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2011
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depressionLobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, et al.
Journal of Pharmaceutical Sciences|December 16, 2011
On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and humanSami S Zoghbi, Kacey B Anderson, Kimberly J Jenko, et al.
Journal of Affective Disorders|November 5, 2016
Sleep architecture parameters as a putative biomarker of suicidal ideation in treatment-resistant depressionRebecca A Bernert, David A Luckenbaugh, Wallace C Duncan, et al.
Bipolar Disorders|September 12, 2007
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot studyCarlos A Zarate, Jaskaran B Singh, Paul J Carlson, et al.
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
Psychiatry Research|August 9, 2017
Active suicidal ideation during clinical antidepressant trialsElizabeth D Ballard, Sam L Snider, Allison C Nugent, et al.
Journal of Affective Disorders|February 19, 2008
Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depressionChristoph Czermak, Richard Hauger, Wayne C Drevets, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 30, 2011
Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremorDietrich Haubenberger, Daniel Kalowitz, Fatta B Nahab, et al.
Biological Psychiatry|June 4, 2013
Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depressionMark J Niciu, David A Luckenbaugh, Dawn F Ionescu, et al.
Comprehensive Psychiatry|September 15, 2016
Recognition of emotional facial expressions in anxious and nonanxious depressionHannah E Berg, Elizabeth D Ballard, David A Luckenbaugh, et al.
Bipolar Disorders|May 29, 2016
Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD studyElizabeth D Ballard, Jennifer L Vande Voort, David A Luckenbaugh, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2011
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depressionLobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, et al.
Journal of Pharmaceutical Sciences|December 16, 2011
On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and humanSami S Zoghbi, Kacey B Anderson, Kimberly J Jenko, et al.
Journal of Affective Disorders|November 5, 2016
Sleep architecture parameters as a putative biomarker of suicidal ideation in treatment-resistant depressionRebecca A Bernert, David A Luckenbaugh, Wallace C Duncan, et al.
Bipolar Disorders|September 12, 2007
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot studyCarlos A Zarate, Jaskaran B Singh, Paul J Carlson, et al.
Pageof 14